Basic Information
| RNALocate ID: | RLID:11001367 |
| RNA Symbol: | hsa-miR-7-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-7-5p |
| RNA ID: | miRBase:MIMAT0000252 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24683445 |
| Tissue/Cell Line: | Serum |
| Method: | Next-generation RNA sequencing |
| Description: | Exosomes are enriched with miRNA: Small RNA libraries of the samples described above were constructed for small RNA-seq by NGS. The number of miRNA identified in this study was 943 of 2,233 known mature miRNA from miRBase V.20. Mapping to Ensembl Release 74 was performed to identify other non-coding RNA such as tRNA, rRNA, small nucleolar RNA (snoRNA) and LincRNA. The average across all 3 samples was calculated to obtain a representative profile of biological diversity between patients (standard deviations of reads in Supplementary file). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001595 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001596 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001597 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001363 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
| RLID:11001364 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001365 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001366 | Exosome | Brain tissue | 23382797 |
| RLID:11001368 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11001369 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:21000261 | Cell body | HEK-293 cells|HeLa cells | 23446346 |
| RLID-D:11000045 | Exosome | Chronic lymphocytic leukemia cells|Colon tissue|Epithelial cells|Tongue tissue | |
| RLID-D:11000314 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-7-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-68783 |
| MNDR | hsa-miR-7-5p | Tongue squamous cell carcinoma | MNDR-E-MI-68784 |
| MNDR | hsa-miR-7-5p | Oral squamous cell carcinoma | MNDR-E-MI-68785 |
| MNDR | hsa-miR-7-5p | Large cell neuroendocrine cancer | MNDR-E-MI-68786 |
| MNDR | hsa-miR-7-5p | Medulloblastoma | MNDR-E-MI-68787 |
| MNDR | hsa-miR-7-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-68788 |
| MNDR | hsa-miR-7-5p | Ovarian serous carcinoma | MNDR-E-MI-68789 |
| MNDR | hsa-miR-7-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68790 |
| MNDR | hsa-miR-7-5p | Autism spectrum disorder | MNDR-E-MI-68791 |
| MNDR | hsa-miR-7-5p | Lymphoma | MNDR-E-MI-68792 |
| MNDR | hsa-miR-7-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68793 |
| MNDR | hsa-miR-7-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68794 |
| MNDR | hsa-miR-7-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68795 |
| MNDR | hsa-miR-7-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68796 |
| MNDR | hsa-miR-7-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68797 |
| MNDR | hsa-miR-7-5p | Breast cancer luminal | MNDR-E-MI-68798 |
| MNDR | hsa-miR-7-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68799 |
| MNDR | hsa-miR-7-5p | Dermatomyositis | MNDR-E-MI-68800 |
| MNDR | hsa-miR-7-5p | Prostate cancer | MNDR-E-MI-68801 |
| MNDR | hsa-miR-7-5p | Gastric cancer | MNDR-E-MI-68802 |
| MNDR | hsa-miR-7-5p | Alzheimer disease | MNDR-E-MI-68803 |
| MNDR | hsa-miR-7-5p | Intracranial aneurysm | MNDR-E-MI-68804 |
| MNDR | hsa-miR-7-5p | Bladder cancer | MNDR-E-MI-68805 |
| MNDR | hsa-miR-7-5p | Polycystic ovary syndrome | MNDR-E-MI-68806 |
| MNDR | hsa-miR-7-5p | Myotonic dystrophy | MNDR-E-MI-68807 |
| MNDR | hsa-miR-7-5p | Head and neck cancer | MNDR-E-MI-68808 |
| MNDR | hsa-miR-7-5p | Leukemia | MNDR-E-MI-68809 |
| MNDR | hsa-miR-7-5p | Huntington disease | MNDR-E-MI-68810 |
| MNDR | hsa-miR-7-5p | Chorea | MNDR-E-MI-68811 |
| MNDR | hsa-miR-7-5p | Cardiovascular disease | MNDR-E-MI-68812 |
| MNDR | hsa-miR-7-5p | Neurodegenerative diseases | MNDR-E-MI-68813 |
| MNDR | hsa-miR-7-5p | Brain cancer | MNDR-E-MI-68814 |
| MNDR | hsa-miR-7-5p | Lung cancer | MNDR-E-MI-68815 |
| MNDR | hsa-miR-7-5p | Fragile x syndrome | MNDR-E-MI-68816 |
| MNDR | hsa-miR-7-5p | Parkinson disease | MNDR-E-MI-68817 |
| MNDR | hsa-miR-7-5p | Basal-like breast cancer | MNDR-E-MI-68818 |
| MNDR | hsa-miR-7-5p | Neuroendocrine neoplasia | MNDR-E-MI-68819 |
| MNDR | hsa-miR-7-5p | Thyroid cancer | MNDR-E-MI-68820 |
| MNDR | hsa-miR-7-5p | Pancreatic cancer | MNDR-E-MI-68821 |
| MNDR | hsa-miR-7-5p | Malignant melanoma | MNDR-E-MI-68822 |
| MNDR | hsa-miR-7-5p | Rectum adenocarcinoma | MNDR-E-MI-68823 |
| MNDR | hsa-miR-7-5p | Colon cancer | MNDR-E-MI-68824 |
| MNDR | hsa-miR-7-5p | Ischemic attack transient | MNDR-E-MI-68825 |
| MNDR | hsa-miR-7-5p | Colon adenocarcinoma | MNDR-E-MI-68826 |
| MNDR | hsa-miR-7-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68827 |
| MNDR | hsa-miR-7-5p | Ovarian cancer | MNDR-E-MI-68828 |
| MNDR | hsa-miR-7-5p | Prostate adenocarcinoma | MNDR-E-MI-68829 |
| MNDR | hsa-miR-7-5p | Carcinoma ductal breast | MNDR-E-MI-68830 |
| MNDR | hsa-miR-7-5p | Glioblastoma | MNDR-E-MI-68831 |
| MNDR | hsa-miR-7-5p | Astrocytoma | MNDR-E-MI-68832 |
| MNDR | hsa-miR-7-5p | Glioma | MNDR-E-MI-68833 |
| MNDR | hsa-miR-7-5p | Oligodendroglioma | MNDR-E-MI-68834 |
| MNDR | hsa-miR-7-5p | Schwannoma | MNDR-E-MI-68835 |
| MNDR | hsa-miR-7-5p | Osteosarcoma | MNDR-E-MI-68836 |
| MNDR | hsa-miR-7-5p | Breast carcinoma | MNDR-E-MI-68837 |
| MNDR | hsa-miR-7-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68838 |
| MNDR | hsa-miR-7-5p | Infarction middle cerebral artery | MNDR-E-MI-68839 |
| MNDR | hsa-miR-7-5p | Meningioma | MNDR-E-MI-68840 |
| MNDR | hsa-miR-7-5p | Uterus cancer | MNDR-E-MI-68841 |
| MNDR | hsa-miR-7-5p | Gastric adenocarcinoma | MNDR-E-MI-68842 |
| MNDR | hsa-miR-7-5p | Pituitary adenoma | MNDR-E-MI-68843 |
| MNDR | hsa-miR-7-5p | Lung squamous cell carcinoma | MNDR-E-MI-68844 |
| MNDR | hsa-miR-7-5p | Carcinoma lung non-small-cell | MNDR-E-MI-68845 |
| MNDR | hsa-miR-7-5p | Lung adenocarcinoma | MNDR-E-MI-68846 |
| MNDR | hsa-miR-7-5p | Adrenocortical cancer | MNDR-E-MI-68847 |
| MNDR | hsa-miR-7-5p | Thyroid carcinoma | MNDR-E-MI-68848 |
| MNDR | hsa-miR-7-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68849 |
| MNDR | hsa-miR-7-5p | Scleroderma | MNDR-E-MI-68850 |
| MNDR | hsa-miR-7-5p | Renal cell carcinoma | MNDR-E-MI-68851 |
| MNDR | hsa-miR-7-5p | Large cell carcinoma | MNDR-E-MI-68852 |
| MNDR | hsa-miR-7-5p | Cholangiocarcinoma | MNDR-E-MI-68853 |
| MNDR | hsa-miR-7-5p | Esophageal cancer | MNDR-E-MI-68854 |
| MNDR | hsa-miR-7-5p | Lung small cell carcinoma | MNDR-E-MI-68855 |
| MNDR | hsa-miR-7-5p | Schizophrenia | MNDR-E-MI-68856 |
| MNDR | hsa-miR-7-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-68857 |
| MNDR | hsa-miR-7-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68858 |
| MNDR | hsa-miR-7-5p | Breast invasive carcinoma | MNDR-E-MI-68859 |
| MNDR | hsa-miR-7-5p | Hepatocellular carcinoma | MNDR-E-MI-68860 |
| MNDR | hsa-miR-7-5p | T-cell leukemia | MNDR-E-MI-68861 |
| MNDR | hsa-miR-7-5p | Neuroblastoma | MNDR-E-MI-68862 |
| MNDR | hsa-miR-7-5p | Hodgkin lymphoma | MNDR-E-MI-68863 |
| MNDR | hsa-miR-7-5p | Burkitt lymphoma | MNDR-E-MI-68864 |
| MNDR | hsa-miR-7-5p | Mouth neoplasms | MNDR-E-MI-68865 |
| MNDR | hsa-miR-7-5p | Tonsil cancer | MNDR-E-MI-68866 |
| MNDR | hsa-miR-7-5p | Colorectal cancer | MNDR-E-MI-68867 |
| MNDR | hsa-miR-7-5p | Multiple myeloma | MNDR-E-MI-68868 |
| MNDR | hsa-miR-7-5p | Acute lymphocytic leukemia | MNDR-E-MI-68869 |
| MNDR | hsa-miR-7-5p | Ovarian epithelial cancer | MNDR-E-MI-68870 |
| MNDR | hsa-miR-7-5p | Thyroid cancer papillary | MNDR-E-MI-68871 |
| MNDR | hsa-miR-7-5p | Uterine cervical neoplasms | MNDR-E-MI-68872 |
| MNDR | hsa-miR-7-5p | Ependymoma | MNDR-E-MI-68873 |
| MNDR | hsa-miR-7-5p | Prostatic neoplasms | MNDR-E-MI-68874 |
| MNDR | hsa-miR-7-5p | Aids dementia complex | MNDR-E-MI-68875 |
| MNDR | hsa-miR-7-5p | Epstein-barr virus infections | MNDR-E-MI-68876 |
| MNDR | hsa-miR-7-5p | Mptp poisoning | MNDR-E-MI-68877 |
| MNDR | hsa-miR-7-5p | Pancreatitis chronic | MNDR-E-MI-68878 |
| MNDR | hsa-miR-7-5p | Stroke lacunar | MNDR-E-MI-68879 |
| MNDR | hsa-miR-7-5p | Breast cancer her3+ negative | MNDR-E-MI-68880 |
| MNDR | hsa-miR-7-5p | Duke C | MNDR-E-MI-68881 |
| MNDR | hsa-miR-7-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68882 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC1 | Homo sapiens | RR00023331 |
TOP